Chemokine CX3CL1 protects rat hippocampal neurons against glutamate-mediated excitotoxicity. - Wikidata - wikimedia - TriplyDB

Chemokine CX3CL1 protects rat hippocampal neurons against glutamate-mediated excitotoxicity.

Chemokine CX3CL1 protects rat hippocampal neurons against glutamate-mediated excitotoxicity.

http://www.wikidata.org/entity/Q46600135

about

CX3CL1 is up-regulated in the rat hippocampus during memory-associated synaptic plasticity CX3CL1/CX3CR1 in Alzheimer's Disease: A Target for Neuroprotection Alzheimer's Disease: Mechanism and Approach to Cell Therapy Cellular and molecular mediators of neuroinflammation in the pathogenesis of Parkinson's disease The neuron-astrocyte-microglia triad in normal brain ageing and in a model of neuroinflammation in the rat hippocampus Fractalkine/CX3CL1 enhances GABA synaptic activity at serotonin neurons in the rat dorsal raphe nucleus Analysis of the Role of CX3CL1 (Fractalkine) and Its Receptor CX3CR1 in Traumatic Brain and Spinal Cord Injury: Insight into Recent Advances in Actions of Neurochemokine Agents.Expression of fractalkine receptor CX3CR1 on cochlear macrophages influences survival of hair cells following ototoxic injury.Enriched environment reduces glioma growth through immune and non-immune mechanisms in mice Interactions between chemokines: regulation of fractalkine/CX3CL1 homeostasis by SDF/CXCL12 in cortical neurons.Differential neuroprotective activity of two different grape seed extracts.Modulating neurotoxicity through CX3CL1/CX3CR1 signaling.HIV-associated neurocognitive disorder: pathogenesis and therapeutic opportunities.Protracted downregulation of CX3CR1 on microglia of aged mice after lipopolysaccharide challenge CX3CL1 (fractalkine) protein expression in normal and degenerating mouse retina: in vivo studies.Role of fractalkine/CX3CR1 interaction in light-induced photoreceptor degeneration through regulating retinal microglial activation and migration CX3CR1 deficiency alters microglial activation and reduces beta-amyloid deposition in two Alzheimer's disease mouse models.Fractalkine attenuates excito-neurotoxicity via microglial clearance of damaged neurons and antioxidant enzyme heme oxygenase-1 expression Interactions between chemokine and mu-opioid receptors: anatomical findings and electrophysiological studies in the rat periaqueductal grey.CX3CR1 protein signaling modulates microglial activation and protects against plaque-independent cognitive deficits in a mouse model of Alzheimer disease.Defective microglial development in the hippocampus of Cx3cr1 deficient mice.The critical role of antigen-presentation-induced cytokine crosstalk in the central nervous system in multiple sclerosis and experimental autoimmune encephalomyelitis.Involvement of CX3CL1/CX3CR1 signaling in spinal long term potentiation.Neuronal Cx3cr1 Deficiency Protects against Amyloid β-Induced Neurotoxicity.Temporal mRNA profiles of inflammatory mediators in the murine 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrimidine model of Parkinson's disease Fractalkine-induced MFG-E8 leads to enhanced apoptotic cell clearance by macrophages Time-dependent effects of CX3CR1 in a mouse model of mild traumatic brain injury Higher plasma fractalkine is associated with better 6-month outcome from ischemic stroke.Fractalkine Attenuates Microglial Cell Activation Induced by Prenatal Stress.Neuronal chemokines: versatile messengers in central nervous system cell interaction.Multi-targeted neuroprotection by the HSV-2 gene ICP10PK includes robust bystander activity through PI3-K/Akt and/or MEK/ERK-dependent neuronal release of vascular endothelial growth factor and fractalkine.HIV-1 Tat disrupts CX3CL1-CX3CR1 axis in microglia via the NF-κBYY1 pathway Intra-neural administration of fractalkine attenuates neuropathic pain-related behaviour Neuron-glia crosstalk in health and disease: fractalkine and CX3CR1 take centre stage.Role of fractalkine/CX3CL1 and its receptor in the pathogenesis of inflammatory and malignant diseases with emphasis on B cell malignancies.Fractalkine Mediates Communication between Pathogenic Proteins and Microglia: Implications of Anti-Inflammatory Treatments in Different Stages of Neurodegenerative Diseases.Fractalkine/CX3CR1 signaling during neuropathic pain.NMDA receptor modulation by the neuropeptide apelin: implications for excitotoxic injury Fractalkine in the nervous system: neuroprotective or neurotoxic molecule?The complex contribution of chemokines to neuroinflammation: switching from beneficial to detrimental effects.

P2860

6483ec7865591f4a350ed95569821047076d40ae c0ebaa70e4e477578c2add4fa129e4fde500419b eb861cfc687c63ea342ce0dcc8035cf9851b3a2b

P248

Q21129473-27F8D7C6-D601-4A20-9EA3-5966A95AD224 Q26739374-41B389B3-7F50-4AA3-ADC2-95D375604AE5 Q26778149-FD00D65C-D91E-4B59-ADFD-1C795074CA0B Q26849232-FFA2C9F5-DC06-4DEA-915B-B0C1EDC2B6D6 Q27318419-2450BE8E-A7F2-4CCE-8648-CB9664A6EC2B Q28570501-15AF41AD-B776-4FC2-9D2C-060CAC0D09BD Q30360306-BFF18F33-9BB7-4A3B-BD69-53253C69A08F Q30475313-A6B1BE63-5DC1-471E-ABD4-ABAC47C8A7BF Q30636900-B8E261AC-6EEB-4272-BF8B-0F2D3E75F3FB Q33796131-33E29C49-A8FE-432C-9863-86521348EB3B Q33808965-644CDA3D-7DA5-4F00-B2C3-A80C44A98D1E Q34019783-65E482F1-B625-4BDF-91CD-9BB360E82432 Q34037622-0C218736-ED8C-485C-ADD5-0735473EEEDC Q34127089-6657B635-5435-4A2E-8245-D306CAF404D3 Q34142149-280576F9-716F-4A94-93A1-F948C06AE7A0 Q34247267-9D160676-15D5-49B5-9B66-869C8838E304 Q34254575-C242F9E7-0251-4AE0-BD1D-1ECF1966CD6F Q34503290-5E2B059D-B6CB-4B10-ADEE-B7C2E5C9DB67 Q34511063-9F5D948B-70E1-444A-923D-8C45B41A6DB9 Q35213298-D67CC5C7-5CB5-430F-AC51-810C48C1C267 Q35233700-B0C75F04-0D90-48BF-91BE-01B126D3AEC8 Q35294476-0A67114D-E86A-4F0B-9A4A-E7817B47CEBE Q35576920-404588CD-9234-4B8F-889F-EE9AE017FF25 Q35650827-2F3D9C1A-B0B6-4EC0-92B8-0A1FDDEC8E91 Q35846770-689290AE-896E-4A09-B2AB-FF6CAECC325C Q35920318-E4D63C07-E467-441C-81DF-56D197930516 Q36020203-7E0F1F44-1C90-4A23-ABEC-74211E3F663F Q36195292-34A4EBCB-86EA-4FF4-92EE-733D01B4E394 Q36889750-49A8DFFD-6775-444E-91D6-A996215022C6 Q36977783-F0F57C87-A7F8-4775-AF77-F0EFB9DCBF9D Q37207631-1CD106BF-6300-4775-A655-A58A593872A7 Q37213105-EAB83AA6-AD26-4026-8E73-C3D87356EA0E Q37305415-304D5E53-71CA-4C8E-91AD-BA588C957111 Q37424844-4989D119-6CA4-478F-9809-C1D780BDA898 Q37700771-C7792E16-26BF-470D-823B-EBD57A39E0CC Q38037524-4884325C-39D7-4623-9F44-5AC6B429D0ED Q38213379-AC9F3F8A-8AB0-440B-8A8C-235E49D3C986 Q38295226-8259241A-6D53-4F7E-A15B-8F5A27A07277 Q38530348-9520323C-F432-4956-BA85-7AFBCAF222C3 Q38562255-880A6B96-9A59-4FBC-A0C6-D6BF29CD1DEC

P2860

Chemokine CX3CL1 protects rat hippocampal neurons against glutamate-mediated excitotoxicity.

http://www.wikidata.org/entity/Q46600135

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh-hant

name

Chemokine CX3CL1 protects rat ...... amate-mediated excitotoxicity.

@en

Chemokine CX3CL1 protects rat ...... amate-mediated excitotoxicity.

@nl

type

label

Chemokine CX3CL1 protects rat ...... amate-mediated excitotoxicity.

@en

Chemokine CX3CL1 protects rat ...... amate-mediated excitotoxicity.

@nl

prefLabel

Chemokine CX3CL1 protects rat ...... amate-mediated excitotoxicity.

@en

Chemokine CX3CL1 protects rat ...... amate-mediated excitotoxicity.

@nl

P1433

Q46600135-0B1E2E3C-DEE4-42CB-B832-EF344F7DFACE

P1476

Q46600135-751A33E8-E5BC-4AF7-826E-175301C2C7AD

P2093

Q46600135-04A872FD-7492-4A00-B29E-DFF4390BFA98

Q46600135-390B71AD-01D4-4968-B41F-1209CAF0C987

Q46600135-41FBED54-6A87-4AE8-B5EC-583796EABD2C

Q46600135-53CB5D7F-505F-4CC1-ABD9-D09F839FF666

Q46600135-9A6758D4-8DD0-4172-8B37-8090D58E86D7

Q46600135-CAC6C427-A9CE-4489-9592-5AB6B79320DC

P304

Q46600135-417A92D8-ED4C-470C-800E-79C59EDD4DE2

P31

Q46600135-F30DFA03-519B-4941-8FDD-B44CD6D26BD9

P356

Q46600135-E2CB00BA-F17F-4779-94F7-D8A9FA3D7E35

P433

Q46600135-73202C70-2A9E-43CF-B186-CBEC6284669E

P478

Q46600135-6B702584-A4A7-462C-91A6-9738C73C2750

P50

Q46600135-7F7D3769-2AEC-4462-B272-704F8A921019

Q46600135-96E14DA0-ACC4-4174-AFD4-C88FCB887EC3

P577

Q46600135-1E7979B2-DA6D-4F4E-A9B8-1A8E5A80E073

P5875

Q46600135-296B1738-61D5-463E-8AB8-CD76B006756F

P698

Q46600135-D5985B03-C7BE-4045-8E07-F7E20C835AD8

P921

Q46600135-0D331A39-F9DE-4794-82FD-C4E3738A0713

Q46600135-60DF5C4E-CDFD-4379-9ABE-17B3D65A5180

P356

J.JNEUROIM.2005.03.023

P1433

Journal of Neuroimmunology

P1476

Chemokine CX3CL1 protects rat ...... amate-mediated excitotoxicity.

@en

P2093

Clotilde Lauro

http://www.w3.org/2001/XMLSchema#string

Cristina Bertollini

http://www.w3.org/2001/XMLSchema#string

Cristina Limatola

http://www.w3.org/2001/XMLSchema#string

Davide Ragozzino

http://www.w3.org/2001/XMLSchema#string

Fabrizio Eusebi

http://www.w3.org/2001/XMLSchema#string

Silvia Di Angelantonio

http://www.w3.org/2001/XMLSchema#string

P304

19-28

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JNEUROIM.2005.03.023

http://www.w3.org/2001/XMLSchema#string

P433

1-2

http://www.w3.org/2001/XMLSchema#string

P478

166

http://www.w3.org/2001/XMLSchema#string

P50

Myriam Catalano

Maria Teresa Ciotti

P577

2005-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7725717

http://www.w3.org/2001/XMLSchema#string

P698

16019082

http://www.w3.org/2001/XMLSchema#string

P921

C-X3-C motif chemokine receptor 1